Dr. Nevena M. Tomašević (née Stanković) has been employed at the Faculty of Science, University of Kragujevac, since 2012, where she currently works as a Teaching Assistant at the Institute of Chemistry. She has received multiple awards as the highest-rated teaching assistant by the Student Parliament and the Faculty. She was awarded a scholarship by the Ministry of Education, Science and Technological Development of the Republic of Serbia for postdoctoral research at the University of Freiburg (Germany), in the group of Prof. Dr. Manfred Jung.
She has been continuously involved in nationally funded research projects since 2012, participating in three national and one international project. She is currently the leader of Work Package 3 within the SMAIPROTACs project funded by the Science Fund of the Republic of Serbia, focused on developing novel therapies for spinal muscular atrophy. Her research interests include biochemistry, medicinal chemistry, and epigenetics.
Dr. Tomašević has authored 29 scientific papers and over 50 conference contributions. She has established international collaborations with researchers from several European countries and beyond. She is a member of the Serbian Chemical Society and the Biochemical Society of Serbia, and she contributed to the organization of their 2024 conference. She is also a co-author of university and primary school textbooks and actively promotes science through outreach activities.
Dr. Nevena M. Tomašević (née Stanković) has been employed at the Faculty of Science, University of Kragujevac, since 2012, where she currently works as a Teaching Assistant at the Institute of Chemistry. She has received multiple awards as the highest-rated teaching assistant by the Student Parliament and the Faculty. She was awarded a scholarship by the Ministry of Education, Science and Technological Development of the Republic of Serbia for postdoctoral research at the University of Freiburg (Germany), in the group of Prof. Dr. Manfred Jung.
She has been continuously involved in nationally funded research projects since 2012, participating in three national and one international project. She is currently the leader of Work Package 3 within the SMAIPROTACs project funded by the Science Fund of the Republic of Serbia, focused on developing novel therapies for spinal muscular atrophy. Her research interests include biochemistry, medicinal chemistry, and epigenetics.
Dr. Tomašević has authored 29 scientific papers and over 50 conference contributions. She has established international collaborations with researchers from several European countries and beyond. She is a member of the Serbian Chemical Society and the Biochemical Society of Serbia, and she contributed to the organization of their 2024 conference. She is also a co-author of university and primary school textbooks and actively promotes science through outreach activities.